Contact Allergy to Allergens in the Swedish Baseline Series Overrepresented in Diabetes Patients with Skin Reactions to Medical Devices – A Retrospective Study from Southern Sweden
DOI:
https://doi.org/10.2340/actadv.v104.19676Keywords:
allergic contact dermatitis, diabetes type 1, continuous glucose monitoring (CGM), insulin pump, isobornyl acrylate, patch testingAbstract
Allergic contact dermatitis is reported among individuals using continuous glucose monitoring systems and insulin pumps. The aim of this study was to describe contact allergy patterns for allergens in the Swedish baseline series and medical device-related allergens among users. Contact allergy to baseline series allergens and isobornyl acrylate was compared between diabetes patients and dermatitis patients patch-tested at the Department of Occupational and Environmental Dermatology during 2017 to 2020. Fifty- four diabetes patients and 2,567 dermatitis patients were included. The prevalence of contact allergy to fragrance mix II and sesquiterpene lactone mix was significantly higher in diabetes patients compared with dermatitis patients. Of the diabetes patients 13.0% and of the dermatitis patients 0.5% tested positive to sesquiterpene lactone mix (p < 0.001). Of the diabetes patients 7.4% and of the dermatitis patients 2.3% tested positive to fragrance mix II (p = 0.041). Of the diabetes patients 70.4% tested positive to medical device-related allergens. Of the diabetes patients 63.0% and of the dermatitis patients 0.2% were allergic to isobornyl acrylate (p < 0.001). In conclusion, not only medical device-related contact allergies, but also contact allergy to baseline series allergens (fragrance mix II and sesquiterpene lactone mix), is overrepresented in diabetes patients who use medical devices.
Downloads
References
Raison-Peyron N, Mowitz M, Bonardel N, Aerts O, Bruze M. Allergic contact dermatitis caused by isobornyl acrylate in OmniPod, an innovative tubeless insulin pump. Contact Dermatitis 2018; 79: 76-80.
https://doi.org/10.1111/cod.12995 DOI: https://doi.org/10.1111/cod.12995
Herman A, Baeck M, de Montjoye L, Bruze M, Giertz E, Goossens A, et al. Allergic contact dermatitis caused by isobornyl acrylate in the Enlite glucose sensor and the Paradigm MiniMed Quick-set insulin infusion set. Contact Dermatitis 2019; 81: 432-437.
https://doi.org/10.1111/cod.13374 DOI: https://doi.org/10.1111/cod.13374
Malinauskiene L, Slekyte G, Mowitz M, Isaksson M, Zablockis R. Allergic contact dermatitis caused by isobornyl acrylate in two patients treated for idiopathic pulmonary arterial hypertension. Contact Dermatitis 2020; 83: 170-171.
https://doi.org/10.1111/cod.13617 DOI: https://doi.org/10.1111/cod.13617
Renaudin H, Darrigade AS, Dendooven E, Foubert K, Aerts O, Milpied B. Allergic contact dermatitis from a disposable blood pressure cuff containing isobornyl acrylate and 2-phenoxyethyl acrylate. Contact Dermatitis 2021; 84: 462-464.
https://doi.org/10.1111/cod.13761 DOI: https://doi.org/10.1111/cod.13761
Hamnerius N, Mowitz M. Intense skin reaction to a new glucose monitoring and insulin pump system. Contact Dermatitis 2020; 83: 524-527.
https://doi.org/10.1111/cod.13663 DOI: https://doi.org/10.1111/cod.13663
Herman A, Aerts O, Baeck M, Bruze M, De Block C, Goossens A, et al. Allergic contact dermatitis caused by isobornyl acrylate in Freestyle(R) Libre, a newly introduced glucose sensor. Contact Dermatitis 2017; 77: 367-373.
https://doi.org/10.1111/cod.12866 DOI: https://doi.org/10.1111/cod.12866
Herman A, Mowitz M, Aerts O, Pyl J, de Montjoye L, Goossens A, et al. Unexpected positive patch test reactions to sesquiterpene lactones in patients sensitized to the glucose sensor FreeStyle Libre. Contact Dermatitis 2019; 81: 354-367.
https://doi.org/10.1111/cod.13330 DOI: https://doi.org/10.1111/cod.13330
Dendooven E, Foubert K, Goossens A, Gilles P, De Borggraeve W, Pieters L, et al. Concomitant positive patch test reactions in FreeStyle-allergic patients sensitized to isobornyl acrylate. Contact Dermatitis 2021; 84: 166-174.
https://doi.org/10.1111/cod.13706 DOI: https://doi.org/10.1111/cod.13706
Ulriksdotter J, Svedman C, Bruze M, Mowitz M. Allergic contact dermatitis caused by dipropylene glycol diacrylate in the Omnipod® insulin pump. Br J Dermatol 2022; 186: 334-340.
https://doi.org/10.1111/bjd.20751 DOI: https://doi.org/10.1111/bjd.20751
Svedman C, Ulriksdotter J, Lejding T, Bruze M, Mowitz M. Changes in adhesive ingredients in continuous glucose monitoring systems may induce new contact allergy pattern. Contact Dermatitis 2021; 84: 439-446.
https://doi.org/10.1111/cod.13781 DOI: https://doi.org/10.1111/cod.13781
Ulriksdotter J, Svedman C, Bruze M, Glimsjö J, Källberg K, Sukakul T, et al. Contact dermatitis caused by glucose sensors - 15 adult patients tested with a medical device patch test series. Contact Dermatitis 2020; 83: 301-309.
https://doi.org/10.1111/cod.13649 DOI: https://doi.org/10.1111/cod.13649
Svedman C, Bruze M, Antelmi A, Hamnerius N, Hauksson I, Ulriksdotter J, et al. Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less 'allergy- prone' devices: investigation and advice hampered by insufficient material for optimized patch test investigations. J Eur Acad Dermatol Venereol 2021; 35: 730-737.
https://doi.org/10.1111/jdv.16981 DOI: https://doi.org/10.1111/jdv.16981
Mowitz M, Herman A, Baeck M, Isaksson M, Antelmi A, Hamnerius N, et al. N,N-dimethylacrylamide-A new sensitizer in the FreeStyle Libre glucose sensor. Contact Dermatitis 2019; 81: 27-31.
https://doi.org/10.1111/cod.13243 DOI: https://doi.org/10.1111/cod.13243
Ulriksdotter J, Mowitz M, Svedman C, Bruze M. Patch testing and diagnosis when suspecting allergic contact dermatitis from medical devices. Contact Dermatitis 2020; 83: 333-335.
https://doi.org/10.1111/cod.13650 DOI: https://doi.org/10.1111/cod.13650
Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis 2015; 73: 195-221.
https://doi.org/10.1111/cod.12432 DOI: https://doi.org/10.1111/cod.12432
Fregert S. Manual of contact dermatitis. Copenhagen: Munksgaard; 1981.
Diepgen TL, Ofenloch RF, Bruze M, Bertuccio P, Cazzaniga S, Coenraads PJ, et al. Prevalence of contact allergy in the general population in different European regions. Br J Dermatol 2016; 174: 319-329.
https://doi.org/10.1111/bjd.14167 DOI: https://doi.org/10.1111/bjd.14167
Rossi M, Coenraads PJ, Diepgen T, Svensson Å, Elsner P, Gonçalo M, et al. Design and feasibility of an international study assessing the prevalence of contact allergy to fragrances in the general population: the European Dermato-Epidemiology Network Fragrance Study. Dermatology 2010; 221: 267-275.
https://doi.org/10.1159/000319757 DOI: https://doi.org/10.1159/000319757
Naldi L, Cazzaniga S, Gonçalo M, Diepgen T, Bruze M, Elsner P, et al. Prevalence of self-reported skin complaints and avoidance of common daily life consumer products in selected European Regions. JAMA Dermatol 2014; 150: 154-163.
https://doi.org/10.1001/jamadermatol.2013.7932 DOI: https://doi.org/10.1001/jamadermatol.2013.7932
de Groot AC. Myroxylon pereirae resin (balsam of Peru) - a critical review of the literature and assessment of the significance of positive patch test reactions and the usefulness of restrictive diets. Contact Dermatitis 2019; 80: 335-353.
https://doi.org/10.1111/cod.13263 DOI: https://doi.org/10.1111/cod.13263
Dendooven E, Foubert K, Naessens T, Pieters L, Lambert J, Goossens A, et al. Allergic contact dermatitis from ("hypoallergenic") adhesives containing D-limonene. Contact Dermatitis 2022; 86: 113-119.
https://doi.org/10.1111/cod.14008 DOI: https://doi.org/10.1111/cod.14008
Heine G, Schnuch A, Uter W, Worm M. Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG). Allergy 2006; 61: 611-616.
https://doi.org/10.1111/j.1398-9995.2006.01029.x DOI: https://doi.org/10.1111/j.1398-9995.2006.01029.x
Hamann CR, Hamann D, Egeberg A, Johansen JD, Silverberg J, Thyssen JP. Association between atopic dermatitis and contact sensitization: a systematic review and meta-analysis. J Am Acad Dermatol 2017; 77: 70-78.
https://doi.org/10.1016/j.jaad.2017.02.001 DOI: https://doi.org/10.1016/j.jaad.2017.02.001
Paulsen E, Andersen KE. Sensitization patterns in Compositae-allergic patients with current or past atopic dermatitis. Contact Dermatitis 2013; 68: 277-285.
https://doi.org/10.1111/cod.12035 DOI: https://doi.org/10.1111/cod.12035
Herman A, Baeck M. Sensitization to isobornyl acrylate in a tertiary Belgian hospital. Contact Dermatitis 2021; 85: 105-106.
https://doi.org/10.1111/cod.13797 DOI: https://doi.org/10.1111/cod.13797
Christoffers WA, Coenraads PJ, Schuttelaar ML. Two decades of occupational (meth)acrylate patch test results and focus on isobornyl acrylate. Contact Dermatitis 2013; 69: 86-92.
https://doi.org/10.1111/cod.12023 DOI: https://doi.org/10.1111/cod.12023
Dendooven E, Dirinck E, Foubert K, Aerts O. "Re-testing" suggests that cosensitizations to isobornyl acrylate and sesquiterpene lactones may be due to cross-reactivity. Contact Dermatitis 2022; 86: 57-59.
https://doi.org/10.1111/cod.13972 DOI: https://doi.org/10.1111/cod.13972
Oppel E, Kamann S, Reichl FX, Hogg C. The Dexcom glucose monitoring system - an isobornyl acrylate-free alternative for diabetic patients. Contact Dermatitis 2019; 81: 32-36.
https://doi.org/10.1111/cod.13248 DOI: https://doi.org/10.1111/cod.13248
Oppel E, Kamann S, Heinemann L, Klein A, Reichl FX, Högg C. Freestyle libre 2: the new isobornyl acrylate free generation. Contact Dermatitis 2020; 83: 429-431.
https://doi.org/10.1111/cod.13638 DOI: https://doi.org/10.1111/cod.13638
Peeters C, Herman A, Goossens A, Bruze M, Mowitz M, Baeck M. Allergic contact dermatitis caused by 2-ethyl cyanoacrylate contained in glucose sensor sets in two diabetic adults. Contact Dermatitis 2017; 77: 426-429.
https://doi.org/10.1111/cod.12873 DOI: https://doi.org/10.1111/cod.12873
Published
How to Cite
License
Copyright (c) 2024 Josefin Ulriksdotter, Thanisorn Sukakul, Magnus Bruze, Martin Mowitz, Robert Ofenloch, Cecilia Svedman
This work is licensed under a Creative Commons Attribution 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
